Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Clinical trial NCT04881929 · UNKNOWN
Trial details
- NCT number
- NCT04881929
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2022-11-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.